Recombinant urate oxidase (SR 29142) to prevent hyperuricaemia during chemotherapy for haematological malignancies.

Recombinant urate oxidase (SR 29142) to prevent hyperuricaemia during chemotherapy for haematological malignancies.

Bibliographic Details
Main Authors:	Littlewood, T, Schuh, A, Haynes, SR
Format:	Journal article
Published:	1998

Similar Items

An Optical Urate Biosensor Based on Urate Oxidase and Long-Lifetime Metalloporphyrins
by: Tokunbo Falohun, et al.
Published: (2020-02-01)

The Relevance of Hyperuricaemia
by: Jan T. Kielstein, et al.
Published: (2016-07-01)

Enhanced production of extracellular urate oxidase by Aspergillus Flavus
by: Wan Ruhayu, Wan Ramli
Published: (2013)

Urate oxidase purification by salting-in crystallization: towards an alternative to chromatography.
by: Marion Giffard, et al.
Published: (2011-05-01)

Cardiovascular and renal effects of hyperuricaemia and gout
by: R. Pontremoli, et al.
Published: (2012-01-01)

Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome
by: Lito E. Papanicolas, et al.
Published: (2021-05-01)

The role of urate and xanthine oxidase in vascular oxidative stress: future directions
by: Jacob George, et al.
Published: (2009-10-01)

Potential role of tea drinking in preventing hyperuricaemia in rats: biochemical and molecular evidence
by: Siyao Sang, et al.
Published: (2022-09-01)

In vivo study of newly developed albumin-conjugated urate oxidase for gout treatment
by: Jeonghaeng Cho, et al.
Published: (2023-12-01)

The first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia
by: Sarah Stewart, et al.
Published: (2015-01-01)

Gout and hyperuricaemia: modifiable cardiovascular risk factors?
by: Michel Burnier
Published: (2023-05-01)

The problems associated with the treatment of chronic hyperuricaemia in Serbia
by: Milosavljević Miloš N., et al.
Published: (2017-01-01)

Hyperuricaemia and the metabolic syndrome in type 2 DM
by: Ogbera Anthonia O, et al.
Published: (2010-04-01)

The problems associated with the treatment of chronic hyperuricaemia in Serbia
by: Milosavljević Miloš N., et al.
Published: (2016-01-01)

Lycium barbarum polysaccharides protect mice from hyperuricaemia through promoting kidney excretion of uric acid and inhibiting liver xanthine oxidase
by: Xin Yu, et al.
Published: (2020-01-01)

Thermostable and Long-Circulating Albumin-Conjugated <i>Arthrobacter globiformis</i> Urate Oxidase
by: Byungseop Yang, et al.
Published: (2021-08-01)

PHYTOPREPARATIONS IN THE PREVENTION AND TREATMENT OF URATE NEPHROLITHIASIS
by: N. G. Chaban, et al.
Published: (2017-12-01)

Hyperuricaemia: prevalence and association with mortality in an elderly Finnish population
by: Hannu Kautiainen, et al.
Published: (2023-05-01)

Update on hyperuricaemia and gout with evidence based management guidelines
by: Girish M. Mody
Published: (2015-07-01)

Evaluation of Association of Hyperuricaemia with Metabolic Syndrome and Insulin Resistance
by: NAVEEN REDDY AVULA, et al.
Published: (2016-12-01)

Incident gout and erectile dysfunction: is hyperuricaemia the elephant in the room?
by: Abhishek Abhishek, et al.
Published: (2017-08-01)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
by: Wardrop, D, et al.
Published: (2013)

Immunotherapy and immunomodulation for haematological malignancies
by: Mussai, F, et al.
Published: (2012)

Anti-Hyperuricemic Effects of Astaxanthin by Regulating Xanthine Oxidase, Adenosine Deaminase and Urate Transporters in Rats
by: Yanzuo Le, et al.
Published: (2020-12-01)

PASylated Urate Oxidase Enzyme: Enhancing Biocatalytic Activity, Physicochemical Properties, and Plasma Half-Life
by: Abbas Najjari, et al.
Published: (2022-12-01)

Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment
by: Rui Zhao, et al.
Published: (2022-12-01)

Revisiting the Effects of Xenon on Urate Oxidase and Tissue Plasminogen Activator: No Evidence for Inhibition by Noble Gases
by: Jesse Cahill, et al.
Published: (2020-09-01)

Alterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats
by: Yiran Yu, et al.
Published: (2018-09-01)

Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
by: Thomas Bardin, et al.
Published: (2017-07-01)

Hyperuricaemia, Hypoparathyroidism and Acute Hypercalcaemia: Unusual Complications in Extrapulmonary Tuberculosis
by: Ravi Parkash, et al.
Published: (2019-09-01)

Advances in Urate Excretion and Urate Transporters in Hyperuricemia
by: XIN Jiadong, ZHOU Jiabao, WU Zhiyuan, ZHANG Xuming, GAO Jiandong
Published: (2023-05-01)

The expression of phosphorylated KDR in haematological malignancies
by: Pillai, G, et al.
Published: (2003)

Bone marrow inflammation in haematological malignancies
by: de Jong, M, et al.
Published: (2024)

Clinical Proteomics of Biofluids in Haematological Malignancies
by: Katie Dunphy, et al.
Published: (2021-07-01)

Immune-epigenetic crosstalk in haematological malignancies
by: Hera Wong, et al.
Published: (2023-09-01)

Targeting hypoxia in solid and haematological malignancies
by: Bill Harris, et al.
Published: (2022-11-01)

Role of tumour angiogenesis in haematological malignancies
by: Michael Medinger, et al.
Published: (2014-11-01)

Haematological Malignancy Presenting in an Unusual Manner
by: Ponvijaya Muthuswamy Yadav, et al.
Published: (2022-09-01)

Targeting translation factors in haematologic malignancies.
by: Lee, Janice Siu Hui.
Published: (2011)

Cap-independent translation in Haematological Malignancies
by: Emilie eHorvilleur, et al.
Published: (2015-12-01)